Healthpeak Properties, Inc. $DOC Shares Purchased by Russell Investments Group Ltd.

Russell Investments Group Ltd. raised its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 176.4% during the third quarter, Holdings Channel reports. The firm owned 3,063,569 shares of the real estate investment trust’s stock after purchasing an additional 1,955,273 shares during the period. Russell Investments Group Ltd.’s holdings in Healthpeak Properties were worth $58,663,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. State Street Corp raised its position in shares of Healthpeak Properties by 0.9% in the 2nd quarter. State Street Corp now owns 48,602,649 shares of the real estate investment trust’s stock worth $851,032,000 after buying an additional 442,481 shares during the period. JPMorgan Chase & Co. grew its position in Healthpeak Properties by 41.0% during the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after acquiring an additional 8,212,504 shares during the period. Geode Capital Management LLC increased its stake in Healthpeak Properties by 1.0% during the second quarter. Geode Capital Management LLC now owns 19,071,094 shares of the real estate investment trust’s stock worth $332,625,000 after acquiring an additional 197,540 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Healthpeak Properties by 2.8% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 10,520,156 shares of the real estate investment trust’s stock worth $184,208,000 after purchasing an additional 282,155 shares during the period. Finally, Cullen Capital Management LLC raised its holdings in shares of Healthpeak Properties by 6.7% in the 3rd quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust’s stock worth $195,960,000 after purchasing an additional 641,771 shares during the period. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Price Performance

DOC stock opened at $17.38 on Wednesday. The firm has a market cap of $12.08 billion, a P/E ratio of 173.83, a price-to-earnings-growth ratio of 9.32 and a beta of 1.11. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82. Healthpeak Properties, Inc. has a 1 year low of $15.71 and a 1 year high of $20.81. The stock has a 50-day simple moving average of $17.14 and a 200-day simple moving average of $17.58.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, topping the consensus estimate of $0.45 by $0.02. The firm had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.Healthpeak Properties’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. On average, equities analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.1017 dividend. The ex-dividend date is Tuesday, March 17th. This represents a c) annualized dividend and a dividend yield of 7.0%. Healthpeak Properties’s dividend payout ratio is 1,220.00%.

Wall Street Analyst Weigh In

DOC has been the subject of a number of research reports. Argus cut Healthpeak Properties from a “buy” rating to a “hold” rating in a report on Thursday, February 5th. Robert W. Baird cut their price target on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a report on Wednesday, November 12th. Evercore reduced their price target on shares of Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 4th. Cantor Fitzgerald set a $17.00 price objective on shares of Healthpeak Properties in a research report on Monday, January 5th. Finally, The Goldman Sachs Group assumed coverage on shares of Healthpeak Properties in a research note on Friday, January 9th. They issued a “neutral” rating and a $17.00 target price on the stock. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, Healthpeak Properties currently has a consensus rating of “Hold” and an average price target of $19.42.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.